RHINEBECK, NY and LONDON: Working in the Converged Technology and Media Sector, Timony Brings Brand Positioning Expertise, Relationship Leveraging Know-How
...
NEW YORK, NY: Company to Develop First-in-Class Galectin-3 Inhibitor, GCS-100, for Organ Failure and Cancer Report Cites the Potential of GCS-100 in Multiple Indications Available for Download at www.lifesciadvisor ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.